China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.250
-0.050 (-1.16%)
Sep 11, 2026, 4:08 PM HKT

HKG:3320 Statistics

Total Valuation

HKG:3320 has a market cap or net worth of HKD 26.70 billion. The enterprise value is 163.52 billion.

Market Cap26.70B
Enterprise Value 163.52B

Important Dates

The last earnings date was Monday, August 24, 2026.

Earnings Date Aug 24, 2026
Ex-Dividend Date Sep 10, 2026

Share Statistics

HKG:3320 has 6.28 billion shares outstanding.

Current Share Class 6.28B
Shares Outstanding 6.28B
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 5.35%
Float 1.83B

Valuation Ratios

The trailing PE ratio is 5.57 and the forward PE ratio is 5.26. HKG:3320's PEG ratio is 0.62.

PE Ratio 5.57
Forward PE 5.26
PS Ratio 0.08
PB Ratio 0.19
P/TBV Ratio 1.33
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio 0.62
Financial Ratio History

Enterprise Valuation

EV / Earnings 34.09
EV / Sales 0.52
EV / EBITDA 8.89
EV / EBIT 11.30
EV / FCF n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.66.

Current Ratio 1.43
Quick Ratio 1.02
Debt / Equity 0.66
Debt / EBITDA 5.02
Debt / FCF n/a
Interest Coverage 6.40

Financial Efficiency

Return on equity (ROE) is 8.32% and return on invested capital (ROIC) is 5.82%.

Return on Equity (ROE) 8.32%
Return on Assets (ROA) 2.64%
Return on Invested Capital (ROIC) 5.82%
Return on Capital Employed (ROCE) 8.32%
Weighted Average Cost of Capital (WACC) 2.00%
Revenue Per Employee 3.74M
Profits Per Employee 57,105
Employee Count84,000
Asset Turnover 0.94
Inventory Turnover 5.23

Taxes

In the past 12 months, HKG:3320 has paid 2.54 billion in taxes.

Income Tax 2.54B
Effective Tax Rate 18.62%

Stock Price Statistics

The stock price has decreased by -14.14% in the last 52 weeks. The beta is -0.40, so HKG:3320's price volatility has been lower than the market average.

Beta (5Y) -0.40
52-Week Price Change -14.14%
50-Day Moving Average 4.68
200-Day Moving Average 4.81
Relative Strength Index (RSI) 26.04
Average Volume (20 Days) 10,474,901

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:3320 had revenue of HKD 314.21 billion and earned 4.80 billion in profits. Earnings per share was 0.76.

Revenue314.21B
Gross Profit 51.41B
Operating Income 14.15B
Pretax Income 13.65B
Net Income 4.80B
EBITDA 18.06B
EBIT 14.15B
Earnings Per Share (EPS) 0.76
Full Income Statement

Balance Sheet

The company has 30.60 billion in cash and 90.61 billion in debt, with a net cash position of -60.02 billion or -9.55 per share.

Cash & Cash Equivalents 30.60B
Total Debt 90.61B
Net Cash -60.02B
Net Cash Per Share -9.55
Equity (Book Value) 137.76B
Book Value Per Share 9.70
Working Capital 72.58B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 3.96B
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 16.36%, with operating and profit margins of 4.50% and 1.53%.

Gross Margin 16.36%
Operating Margin 4.50%
Pretax Margin 4.34%
Profit Margin 1.53%
EBITDA Margin 5.75%
EBIT Margin 4.50%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 5.10%.

Dividend Per Share 0.23
Dividend Yield 5.10%
Dividend Growth (YoY) 77.61%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 5.10%
Earnings Yield 17.97%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Analyst Forecast

The average price target for HKG:3320 is 6.51, which is 53.18% higher than the current price. The consensus rating is "Buy".

Price Target 6.51
Price Target Difference 53.18%
Analyst Consensus Buy
Analyst Count 10
Revenue Growth Forecast (3Y) 4.73%
EPS Growth Forecast (3Y) 6.71%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5